SCHEMBL126418

SCHEMBL126418

CON(N)c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA4 P22748 2/20 0.38
ALDH1A1 P00352 5/20 0.37
KDM4E B2RXH2 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
MAPT P10636 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MEN1 O00255 1/20 0.37
HTT P42858 1/20 0.37
KMT2A Q03164 1/20 0.37
AOC3 Q16853 3/20 0.36
CA12 O43570 2/20 0.33
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33
CA9 Q16790 2/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1707606 0.97 CA4 (0.36) CA4ALDH1A1KDM4ETDP1CYP1A2
Methyl Alcohol SCHEMBL28306735 0.93 ALDH1A1 (0.37) CA4ALDH1A1KDM4ETDP1CYP1A2
Acetonitrile SCHEMBL28320733 0.89 MAPT (0.35) CA4ALDH1A1KDM4ETDP1CYP1A2
SCHEMBL28065680 0.73 AOC3 (0.36) ALDH1A1KDM4ETDP1CYP1A2CYP3A4
SCHEMBL11386184 0.73 TP53 (0.41) ALDH1A1KDM4ETDP1CYP1A2CYP3A4
SCHEMBL210129 0.72 CA4 (0.41) CA4ALDH1A1KDM4ETDP1CYP1A2
SCHEMBL3951063 0.72 CA4 (0.41) CA4ALDH1A1KDM4ETDP1CYP1A2
SCHEMBL2572742 0.72 LTA4H (0.39) CA4ALDH1A1KDM4ETDP1CYP1A2
SCHEMBL28812595 0.72 LMNA (0.38) ALDH1A1KDM4ETDP1CYP1A2CYP3A4
Hydrochloric Acid SCHEMBL21273293 0.70 CA4 (0.39) CA4ALDH1A1KDM4ETDP1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114085179-B Preparation method of N-acetyl-5-methoxy tryptamine 福建科宏生物工程股份有限公司 2024-05-03 CN disclosed
WO-2024017383-A1 ANTI-MCT1 ANTIBODY AND USE THEREOF 佰舟生物科技(苏州)有限公司 2024-01-25 WO disclosed
CN-114085179-A Preparation method of N-acetyl-5-methoxytryptamine 福建科宏生物工程股份有限公司 2022-02-25 CN disclosed
CN-105998016-B Application of pirfenidone derivative in pharmacy 四川大学 2020-08-11 CN disclosed
US-10577327-B2 Pyridine based ionic fluoride for catalyzing indole and tetrazole formation KING ABDULAZIZ UNIVERSITY (SA) 2020-03-03 US disclosed
EP-3298089-A1 INK COMPRISING SILVER NANOPARTICLES Genes'Ink SA (FR) 2018-03-28 EP disclosed
CN-107427005-A Include the Fungicidal mixture of strobilurins type fungicide 巴斯夫欧洲公司 2017-12-01 CN disclosed
CN-103477922-B Polymer composites with biocide functionality 伊玛弗莱克斯股份有限公司 2017-10-10 CN disclosed
EP-3004110-B1 PYRAZOLOPYRROLIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE NOVARTIS AG (CH) 2017-07-26 EP disclosed
WO-2016184979-A1 INK COMPRISING SILVER NANOPARTICLES GENES'INK SA (FR) 2016-11-24 WO disclosed
WO-1995011878-A1 INHIBITORS OF KYNURENINASE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 1995-05-04 WO disclosed
WO-1994013662-A1 (AZAARYLMETHOXY)INDOLES AS INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS MERCK FROSST CANADA INC. (CA) 1994-06-23 WO disclosed
EP-0385336-A2 Processes for the preparation of pterin derivatives NISSHIN FLOUR MILLING CO., LTD. (JP) 1990-09-05 EP disclosed
EP-0361067-A1 Disubstituted naphthalines, preparation processes and their herbicidal use BAYER AG (DE) 1990-04-04 EP disclosed
EP-0114850-B1 NEW SUBSTITUTED DERIVATIVES OF 2,5-DIAMINO 1,4-DIAZOLE, PREPARATION METHODS THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM BOUCHARA S.A. (FR) 1988-06-29 EP disclosed
EP-0174634-B1 IMAGE FORMING METHOD FUJI PHOTO FILM CO., LTD. (JP) 1987-12-09 EP disclosed
EP-0114850-A1 NEW SUBSTITUTED DERIVATIVES OF 2,5-DIAMINO 1,4-DIAZOLE, PREPARATION METHODS THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. BOUCHARA EMILE (FR) 1984-08-08 EP disclosed
WO-1984000546-A1 NEW SUBSTITUTED DERIVATIVES OF 2,5-DIAMINO 1,4-DIAZOLE, PREPARATION METHODS THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM BOUCHARA EMILE (FR) 1984-02-16 WO disclosed
US-3979141-A Pressure-sensitive recording system comprising 3'-amino-6' or 7'-(pyrazol-1-yl)fluoran compounds as color precursors MOORE BUSINESS FORMS, INC. (US) 1976-09-07 US disclosed
US-3964894-A 1-(FURYL OR THIAZOLYL)CARBONYL-2-METHYL-5-METHOXY-INDOL-3-YL ACETIC ACID CHINOIN GYOGYSZER-ES VEGYESZETI TERMEKEK GYARA RT (HU) 1976-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10577327-B2 Pyridine based ionic fluoride for catalyzing indole and tetrazole formation FLI1, ABL1, INMT CA4 1056/4885ALDH1A1 1278/4885KDM4E 2056/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.